The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis
Article in BMC Cancer (June 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in BMC Cancer (June 2024)
Article in Medicina (December 2023)
Article in European Urology (November 2023)